Drug Take-Back Programs Likely To Spread As Supreme Court Denies Industry Petition
This article was originally published in The Tan Sheet
More than 250 pharma companies participate in take-back project in Alameda County, Calif. The volume of covered products and costs to the industry significantly increase when city and county governments adopt ordinances that also include OTC drugs.
You may also be interested in...
Amgen exec calls for more informal agency feedback and alignment between review divisions in understanding design methodologies.